COVID-19 Research Funding

Last Updated May 21, 2020

Intramural Funding: COVID-19 Research Fund

The COVID-19 Research Fund will support new research projects and scholarly activities in the exploration and understanding of COVID-19 through the use of GW shared facilities and resources.

The COVID-19 Research Fund focuses on supporting:

  • pilot projects that generate rapid preliminary data;
  • projects that engage multiple investigators who bring diverse expertise and resources;
  • projects that address aspects of telehealth;
  • projects that propose studies on the repurposing of existing drugs/therapies; and
  • projects that emphasize the use of GW’s core facilities and services.

The funding range for this program is $5,000-$25,000. Submissions will be reviewed on a rolling basis through June 1, 2020.

View the detailed Call for Proposals (PDF)

Submit an application via OVPR’s InfoReady Portal

COVID-19 Technology Maturation Awards

The GW Technology Commercialization Office (TCO) is sponsoring COVID-19 Technology Maturation Awards (TMA) to support potential commercial demonstration projects for academic research outputs in any science and engineering discipline. This demonstration is achieved through proof-of-concept, prototyping, technology development and/or scale-up work. Successful TMA projects generate technology validation necessary to attract experienced licensees.

  • Eligibility: GW faculty inventors with a GW-owned invention available for licensing. If you have a new invention or technology, disclose it to TCO before applying for this award.
  • Funding: Up to $50,000 for 6-12 months per award
  • Deadline: Rolling submission through June 30, 2020

View full details or apply for funding

External Funding Opportunities

Curated Pivot Search

National Institutes of Health (NIH)

National Science Foundation (NSF)

Department of Defense

Patient-Centered Outcomes Research Institute

Corporate and Foundation Funders

Other Lists of Open Funding Opportunities

  • Frontiers, a leading open access publisher, has curated a list of open funding calls and other support for researchers, specifically related to COVID-19 and coronavirus-related research.

Assistance with Funding Searches

OVPR’s Research Enhancement Unit is available to assist investigators in locating appropriate funding mechanisms or refining Pivot searches. Email [email protected] to request a consultation.

Reminder: Limited Submission Opportunities

If a funding opportunity limits the number of submissions from each organization, please notify [email protected] immediately to expedite an internal review and selection process.

Review of Research Involving COVID-19

All of the standard protocol reviews apply to COVID-19 related studies and no new projects may commence without these approvals. However, GW’s review boards have implemented plans to speed the reviews of research protocols involving COVID-19.

  • The Institutional Biosafety Committee has released interim guidance for research involving COVID-19. The IBC will review applications within five business days. The IBC will convene by teleconference or videoconference as necessary to accommodate these submissions.
  • The Institutional Review Board is prioritizing review of these protocols by assembling a standing panel of reviewers that will convene as necessary. For new studies involving COVID-19, please include the term COVID in the study title, and communicate with OHR via [email protected] regarding urgent study needs.
  • The Institutional Animal Care and Use Committee will continue to conduct official business during the COVID-19 pandemic. Alternatives to face-to-face meetings such as teleconference or video conferencing will be employed in order to ensure protocol approvals are not allowed to expire and that high priority submissions are approved within a timely manner.